{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:51:55Z","timestamp":1694620315651},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.leu.2401814","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:36:05Z","timestamp":1031164565000},"page":"1215-1224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"14","author":[{"given":"GA","family":"Hosler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RH","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,17]]},"reference":[{"key":"BF2401814_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJM194806032382301","volume":"238","author":"S Farber","year":"1948","unstructured":"Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA . Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin) N Engl J Med 1948 238: 787\u2013793","journal-title":"N Engl J Med"},{"key":"BF2401814_CR2","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood.V90.11.4243","volume":"90","author":"JH Kersey","year":"1997","unstructured":"Kersey JH . Fifty years of studies of the biology and therapy of childhood leukemia Blood 1997 90: 4243\u20134251","journal-title":"Blood"},{"key":"BF2401814_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00062752-199704040-00003","volume":"4","author":"JE Rubnitz","year":"1997","unstructured":"Rubnitz JE, Pui CH . Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia Curr Opin Hematol 1997 4: 233\u2013241","journal-title":"Curr Opin Hematol"},{"key":"BF2401814_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.bmt.1701013","volume":"20","author":"A Borgmann","year":"1997","unstructured":"Borgmann A, Baumgarten E, Schmid H, Dopfer R, Ebell W, Gobel U, Niethammer D, Gadner H, Henze G . Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? Bone Marrow Transplant 1997 20: 939\u2013944","journal-title":"Bone Marrow Transplant"},{"key":"BF2401814_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<534::AID-MPO3>3.0.CO;2-L","volume":"29","author":"SA Feig","year":"1997","unstructured":"Feig SA, Harris RE, Sather HN . Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884) Med Ped Oncol 1997 29: 534\u2013540","journal-title":"Med Ped Oncol"},{"key":"BF2401814_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1365-2141.1997.3113127.x","volume":"98","author":"JM Chessells","year":"1997","unstructured":"Chessells JM, Harrison G, Lilleyman JS, Bailey CC, Richards SM . Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia Br J Haematol 1997 98: 945\u2013951","journal-title":"Br J Haematol"},{"key":"BF2401814_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia (see comments) J Clin Oncol 1996 14: 18\u201324","journal-title":"J Clin Oncol"},{"key":"BF2401814_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia New Engl J Med 1998 339: 605\u2013615","journal-title":"New Engl J Med"},{"key":"BF2401814_CR9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","volume":"80","author":"PS Gaynon","year":"1997","unstructured":"Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG, Uckun FM . Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review Cancer 1997 80: 1717\u20131726","journal-title":"Cancer"},{"key":"BF2401814_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/10428199509112194","volume":"19","author":"HG Drexler","year":"1995","unstructured":"Drexler HG, Borkhardt A, Janssen JW . Detection of chromosomal translocations in leukemia\u2013lymphoma cells by polymerase chain reaction Leuk Lymphoma 1995 19: 359\u2013380","journal-title":"Leuk Lymphoma"},{"key":"BF2401814_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","volume":"343","author":"MJ Brisco","year":"1994","unstructured":"Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H, Morley AA . Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (see comments) Lancet 1994 343: 196\u2013200","journal-title":"Lancet"},{"key":"BF2401814_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten, Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer \u2013 Childhood Leukemia Cooperative Group (see comments) New Engl J Med 1998 339: 591\u2013598","journal-title":"New Engl J Med"},{"key":"BF2401814_CR13","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1182\/blood.V88.10.3704.bloodjournal88103704","volume":"88","author":"K Tobal","year":"1996","unstructured":"Tobal K, Yin JA . Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21) Blood 1996 88: 3704\u20133709","journal-title":"Blood"},{"key":"BF2401814_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0002-9440(10)65355-2","volume":"154","author":"GA Hosler","year":"1999","unstructured":"Hosler GA, Bai X, Bash RO, Jain V, Scheuermann RH . Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T cell acute lymphoblastic leukemia and follicular lymphoma Am J Pathol 1999 154: 1023\u20131035","journal-title":"Am J Pathol"},{"key":"BF2401814_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/301527a0","volume":"301","author":"GC Bosma","year":"1983","unstructured":"Bosma GC, Custer RP, Bosma MJ . A severe combined immunodeficiency mutation in the mouse Nature 1983 301: 527\u2013530","journal-title":"Nature"},{"key":"BF2401814_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/335256a0","volume":"335","author":"DE Mosier","year":"1988","unstructured":"Mosier DE, Gulizia RJ, Baird SM, Wilson DB . Transfer of a functional human immune system to mice with severe combined immunodeficiency Nature 1988 335: 256\u2013259","journal-title":"Nature"},{"key":"BF2401814_CR17","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.2971269","volume":"241","author":"JM McCune","year":"1988","unstructured":"McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL . The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function Science 1988 241: 1632\u20131639","journal-title":"Science"},{"key":"BF2401814_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood.V84.3.702.702","volume":"84","author":"MA Ghetie","year":"1994","unstructured":"Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES . Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail Blood 1994 84: 702\u2013707","journal-title":"Blood"},{"key":"BF2401814_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/bjc.1994.52","volume":"69","author":"BJ Morland","year":"1994","unstructured":"Morland BJ, Barley J, Boehm D, Flavell SU, Ghaleb N, Kohler JA, Okayama K, Wilkins B, Flavell DJ . Effectiveness of HB2 (anti-CD7)\u2013saporin immunotoxin in an in vivo model of human T cell leukaemia developed in severe combined immunodeficient mice Br J Cancer 1994 69: 279\u2013285","journal-title":"Br J Cancer"},{"key":"BF2401814_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0145-2126(97)00092-1","volume":"21","author":"A Gobbi","year":"1997","unstructured":"Gobbi A, Di Berardino C, Scanziani E, Garofalo A, Rivolta A, Fontana G, Rambaldi A, Giavazzi R, Biondi A . A human acute lymphoblastic leukemia line with the t(4;11) translocation as a model of minimal residual disease in SCID mice Leukemia Res 1997 21: 1107\u20131114","journal-title":"Leukemia Res"},{"key":"BF2401814_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1126\/science.7531365","volume":"267","author":"FM Uckun","year":"1995","unstructured":"Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Bolen J, Myers DE . Biotherapy of B cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases Science 1995 267: 886\u2013891","journal-title":"Science"},{"key":"BF2401814_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/379645a0","volume":"379","author":"N Meydan","year":"1996","unstructured":"Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM . Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor Nature 1996 379: 645\u2013648","journal-title":"Nature"},{"key":"BF2401814_CR23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V88.4.1135.bloodjournal8841135","volume":"88","author":"FM Uckun","year":"1996","unstructured":"Uckun FM . Severe combined immunodeficient mouse models of human leukemia Blood 1996 88: 1135\u20131146","journal-title":"Blood"},{"key":"BF2401814_CR24","volume-title":"Theory and Practice of Histological Techniques (ed 3rd)","author":"RE Nunn","year":"1990","unstructured":"Nunn RE, Rose RA, Hopwood D, Gordon KC, Bradburg P, Horobin RW, Stevens A, Page KM, Lowe J . Theory and Practice of Histological Techniques (ed 3rd) Churchill Livingstone: New York 1990"},{"key":"BF2401814_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gr.6.10.986","volume":"6","author":"CA Heid","year":"1996","unstructured":"Heid CA, Stevens J, Livak KJ, Williams PM . Real time quantitative PCR Genome Res 1996 6: 986\u2013994","journal-title":"Genome Res"},{"key":"BF2401814_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0145-2126(94)90089-2","volume":"18","author":"AR Cattan","year":"1994","unstructured":"Cattan AR, Douglas E . The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo Leukemia Res 1994 18: 513\u2013522","journal-title":"Leukemia Res"},{"key":"BF2401814_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ijc.2910560414","volume":"56","author":"CH Uittenbogaart","year":"1994","unstructured":"Uittenbogaart CH, Anisman DJ, Tary-Lehmann M, Vollger LW, Breit TM, Van Dongen JJ, Saxon A . The SCID mouse environment causes immunophenotypic changes in human immature T-cell lines Int J Cancer 1994 56: 546\u2013551","journal-title":"Int J Cancer"},{"key":"BF2401814_CR28","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","volume":"86","author":"A Gajjar","year":"1995","unstructured":"Gajjar A, Ribeiro R, Hancock ML, Rivera GK, Mahmoud H, Sandlund JT, Crist WM, Pui CH . Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia Blood 1995 86: 1292\u20131295","journal-title":"Blood"},{"key":"BF2401814_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana, D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia (see comments) Lancet 1998 351: 550\u2013554","journal-title":"Lancet"},{"key":"BF2401814_CR30","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V90.3.1226","volume":"90","author":"SP Dibenedetto","year":"1997","unstructured":"Dibenedetto SP, Lo Nigro L, Mayer SP, Rovera G, Schiliro G . Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia Blood 1997 90: 1226\u20131232","journal-title":"Blood"},{"key":"BF2401814_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/0140-6736(92)92625-P","volume":"340","author":"F Lo Coco","year":"1992","unstructured":"Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG . Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia Lancet 1992 340: 1437\u20131438","journal-title":"Lancet"},{"key":"BF2401814_CR32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V81.4.1089.1089","volume":"81","author":"K Miyamura","year":"1993","unstructured":"Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y, Matsuyama K, Hirabayashi N, Yamada H, Naito K, Imai K, Sakamaki H, Asai O, Mizutani S . Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients Blood 1993 81: 1089\u20131093","journal-title":"Blood"},{"key":"BF2401814_CR33","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","volume":"86","author":"C Biernaux","year":"1995","unstructured":"Biernaux C, Loos M, Sels A, Huez G, Stryckmans P . Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals Blood 1995 86: 3118\u20133122","journal-title":"Blood"},{"key":"BF2401814_CR34","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","volume":"85","author":"J Limpens","year":"1995","unstructured":"Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM . Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals Blood 1995 85: 2528\u20132536","journal-title":"Blood"},{"key":"BF2401814_CR35","first-page":"8","volume":"6","author":"S Kamel-Reid","year":"1992","unstructured":"Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M . Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice Leukemia 1992 6: 8\u201317","journal-title":"Leukemia"},{"key":"BF2401814_CR36","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/MCB.10.10.5502","volume":"10","author":"J Cheng","year":"1990","unstructured":"Cheng J, Haas M . Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines Molec Cell Biol 1990 10: 5502\u20135509","journal-title":"Molec Cell Biol"},{"key":"BF2401814_CR37","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","volume":"84","author":"J Imamura","year":"1994","unstructured":"Imamura J, Miyoshi I, Koeffler HP . p53 in hematologic malignancies Blood 1994 84: 2412\u20132421","journal-title":"Blood"},{"key":"BF2401814_CR38","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/sj.onc.1201399","volume":"15","author":"S Geley","year":"1997","unstructured":"Geley S, Hartmann BL, Hattmannstorfer R, Loffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R . p53-induced apoptosis in the human T-ALL cell line CCRF-CEM Oncogene 1997 15: 2429\u20132437","journal-title":"Oncogene"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401814","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:43:29Z","timestamp":1648759409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF2401814"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401814","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]},"assertion":[{"value":"25 November 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}